• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    10/29/24 7:13:25 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email
    SC 13G/A 1 d870440dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES AND EXCHANGE ACT OF 1934

    (Amendment No. 2)*

     

     

    Enfusion, Inc.

    (Name of Issuer)

    Class A common stock

    (Title of Class of Securities)

    292812104

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    SCHEDULE 13G

    CUSIP No. 292812104

     

     1   

     NAME OF REPORTING PERSONS

     

     Malherbe Investments LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     7,870,386 (1)

       6  

     SHARED VOTING POWER

     

     0

       7  

     SOLE DISPOSITIVE POWER

     

     7,870,386 (1)

       8  

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     7,870,386 (1)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     7.86% (2)

    12  

     TYPE OF REPORTING PERSON

     

     OO

     

    (1)

    Represents (i) 1,000,000 shares of Class A common stock held by Malherbe Investments LLC and (ii) 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.

    (2)

    This percentage is based on 100,081,118 shares of Class A Common Stock outstanding, which is the sum of (i) 93,210,732 shares of Class A Common Stock outstanding as of August 2, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on August 6, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


     1   

     NAME OF REPORTING PERSONS

     

     Stephen Malherbe

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     7,870,386 (1)

       6  

     SHARED VOTING POWER

     

     0

       7  

     SOLE DISPOSITIVE POWER

     

     7,870,386 (1)

       8  

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     7,870,386 (1)

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     7.86% (2)

    12  

     TYPE OF REPORTING PERSON

     

     IN

     

    (1)

    Represents (i) 1,000,000 shares of Class A common stock held by Malherbe Investments LLC and (ii) 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.

    (2)

    This percentage is based on 100,081,118 shares of Class A Common Stock outstanding, which is the sum of (i) 93,210,732 shares of Class A Common Stock outstanding as of August 2, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on August 6, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


    Item 1

     

      (a)

    Name of Issuer:

    Enfusion, Inc.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    125 South Clark Street, Suite 750, Chicago, Illinois 60603

     

    Item 2

     

      (a)

    Name of Person Filing:

    This statement is filed by Malherbe Investments LLC and Stephen Malherbe (together, the “Reporting Persons”). Mr. Malherbe is the sole manager of Malherbe Investments LLC and may be deemed the beneficial owner of the shares held by Malherbe Investments LLC.

     

      (b)

    Address of Principal Business Office or, if None, Residence:

    The principal business office address of the Reporting Persons is 1063 Gallant Court, Wheaton, Illinois 60187.

     

      (c)

    Citizenship:

    Malherbe Investments LLC is a Delaware limited liability company and Stephen Malherbe is a citizen of the United States of America.

     

      (d)

    Title of Class of Securities:

    Class A common stock, par value $0.001 per share

     

      (e)

    CUSIP Number:

    292812104

     

    Item

    3 If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a)

    ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     

      (b)

    ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

      (c)

    ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     

      (d)

    ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

     

      (e)

    ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

     

      (f)

    ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

     

      (g)

    ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

     

      (h)

    ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

     

      (i)

    ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

     

      (j)

    ☐ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     

      (k)

    ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    Item 4

    Ownership.

     

      I.

    Malherbe Investments LLC

    (a) Amount beneficially owned: 7,870,386 (1)

    (b) Percent of class: 7.86% (2)

    (c) Number of shares as to which such person has:

     

      (i)

    Sole power to vote or direct the vote: 7,870,386 (1)

     

      (ii)

    Shared power to vote or direct the vote: 0


      (iii)

    Sole power to dispose or direct the disposition: 7,870,386 (1)

     

      (iv)

    Shared power to dispose or direct the disposition: 0

     

      II.

    Stephen Malherbe

    (a) Amount beneficially owned: 7,870,386 (1)

    (b) Percent of class: 7.86% (2)

    (c) Number of shares as to which such person has:

     

      (i)

    Sole power to vote or direct the vote: 7,870,386 (1)

     

      (ii)

    Shared power to vote or direct the vote: 0

     

      (iii)

    Sole power to dispose or direct the disposition: 7,870,386 (1)

     

      (iv)

    Shared power to dispose or direct the disposition: 0

     

      (1)

    Represents (i) 1,000,000 shares of Class A common stock held by Malherbe Investments LLC and (ii) 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.

     

      (2)

    This percentage is based on 100,081,118 shares of Class A Common Stock outstanding, which is the sum of (i) 93,210,732 shares of Class A Common Stock outstanding as of August 2, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on August 6, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.

     

    Item 5

    Ownership of Five Percent or Less of a Class.

    Not applicable.

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group.

    Not applicable.

     

    Item 9

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10

    Certification.

    Not applicable.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: October 29, 2024

     

    Malherbe Investments LLC
    By:  

    /s/ Stephen Malherbe

      Name: Stephen Malherbe
      Title: Sole Manager
    By:  

    /s/ Stephen Malherbe

      Stephen Malherbe


    EXHIBIT INDEX

     

    Exhibit
    No.
      

    Description

    99.1    Joint Filing Agreement, dated as of February 16, 2022 (incorporated by reference to exhibit 99.1 of the Schedule 13G filed by the Reporting Persons on February 16, 2022).
    Get the next $ENFN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    SEC Filings

    See more
    • SEC Form 15-12G filed by Enfusion Inc.

      15-12G - Enfusion, Inc. (0001868912) (Filer)

      5/1/25 4:15:29 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form EFFECT filed by Enfusion Inc.

      EFFECT - Enfusion, Inc. (0001868912) (Filer)

      4/24/25 12:15:09 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form POS AM filed by Enfusion Inc.

      POS AM - Enfusion, Inc. (0001868912) (Filer)

      4/21/25 4:57:41 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OPENLANE Names Brad Herring Chief Financial Officer

      Bolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.

      4/22/25 4:15:00 PM ET
      $ENFN
      $FOUR
      $KAR
      Computer Software: Prepackaged Software
      Technology
      Business Services
      Consumer Discretionary
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

      Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater's acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on April 16, 2025 (the "Election Deadline"). The parties expect to close the Transaction on April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions

      4/17/25 8:00:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:12 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:09 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/21/25 5:11:16 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Enfusion with a new price target

      Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

      5/10/24 8:40:24 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by Goldman with a new price target

      Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

      2/28/24 6:16:11 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by JP Morgan with a new price target

      JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

      1/30/24 6:55:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology